Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name：MC38-hCCL1/hPD-L1 Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230016
CCL1/PD-L1 gene humanized MC38 cell line
Strain Name：MC38-hVEGFA(189) Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-250230
MC38 cell line with humanized VEGFA(189) gene
Strain Name：MC38-hCD47-hCLDN18.2-hB7H3 Strain State ： Construction completed | Cat. NO.：NM-S13-TM71
hCD47&hCLDN18.2&hB7H3 gene humanized MC38 cell line
Strain Name：MC38-hCD47-hCLDN18.2-hB7H4 Strain State ： Construction completed | Cat. NO.：NM-S13-TM72
hCD47&hCLDN18.2&hB7H4 gene humanized MC38 cell line
Strain Name：MC38-hPD-L1/hCLAUDIN 18.2 Strain State ： Construction | Cat. NO.：NMC-230113
PD-L1 and CLAUDIN 18.2 gene humanized MC38 cell line
Strain Name：CT26-hPD-L1/hCLAUDIN 18.2 Strain State ： Construction | Cat. NO.：NMC-230112
PD-L1 and CLAUDIN 18.2 gene humanized CT26 cell line
Model Organisms：小鼠 Product & Service：- Research field：
Humanized mouse models preclinical research targeted therapies webinar oncology drug development preclinical therapeutic advancements immune system models animal modeling services
Join GenoBioTX's webinar on July 25th to explore the latest advancements in humanized mouse models for preclinical research. Learn how these models are transforming targeted therapy development across various diseases. Featuring expert insights from Dr. Derek Reznik, discover the generation and application of humanized immune system models in oncology drug development. Don't miss this opportunity to enhance your knowledge in cutting-edge preclinical therapeutic advancements. Register now!
U-HuDTMbase® is composed of more than 600 therapeutic target-humanized mouse models, including multiple background strains, and has covered almost all commonly studied areas, such as oncology, metabolism, immunity, inflammation and more.
Please fill in the order form and we will contact you within 2 working days.
